4.6 Article

Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial

Xingqi Wu et al.

Summary: Accelerated intermittent theta-burst stimulation (iTBS) in the left dorsolateral prefrontal cortex (DLPFC) has been shown to enhance associative memory (AM) in patients with Alzheimer's disease (AD). Results indicate that patients in the active group showed significant improvements in AM at week 2 and week 10, particularly those with higher baseline Mini-Mental State Examination (MMSE) scores.

BRAIN STIMULATION (2022)

Article Medical Laboratory Technology

Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

Johan Gobom et al.

Summary: The study evaluated the LUMIPULSE G assays for core cerebrospinal fluid biomarkers and established cutpoints for Alzheimer's disease diagnosis. Results showed strong correlation and reliable analytical performance of the LUMIPULSE G assays.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)

Article Immunology

Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration

Kazuhisa Ishida et al.

Summary: This study reveals the role of aquaporin-4 (AQP4) in the clearance of extracellular tau from the brain to cerebrospinal fluid and deep cervical lymph nodes, with the deletion of AQP4 exacerbating tau deposition and neurodegeneration. The findings identify a novel regulatory mechanism of glymphatic clearance in the central nervous system for extracellular tau, which may contribute to tau aggregation and neurodegeneration.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Review Clinical Neurology

Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

Thomas K. Karikari et al.

Summary: This article summarizes the performance of blood phosphorylated tau biomarkers in the context of Alzheimer disease (AD) and discusses the related ethical, analytical, and clinical challenges. It highlights the potential of blood biomarkers as first-line diagnostic and prognostic tools, but emphasizes the need to address outstanding ethical, clinical, and analytical challenges, and standardize inter-laboratory and inter-assay measurements.

NATURE REVIEWS NEUROLOGY (2022)

Article Neurosciences

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum

Johan Gobom et al.

Summary: This study presents the first antibody-free mass spectrometric method for simultaneously measuring multiple phosphorylated epitopes in CSF tau, providing insights into the pathophysiology of Alzheimer's disease and potentially facilitating clinical trials for tau-based drug candidates.

MOLECULAR NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

Filopodia are a structural substrate for silent synapses in adult neocortex

Dimitra Vardalaki et al.

Summary: Newly generated excitatory synapses in the mammalian cortex lack sufficient AMPA-type glutamate receptors to mediate neurotransmission, resulting in functionally silent synapses that require activity-dependent plasticity to mature. However, adults retain a capacity for neural plasticity and flexible learning, suggesting that the formation of new connections is still prevalent. The study found that a significant percentage of synapses lacked AMPA receptors and were located on thin dendritic protrusions. These silent synapses can be activated through a process called Hebbian plasticity.

NATURE (2022)

Article Biochemistry & Molecular Biology

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

Kanta Horie et al.

Summary: Currently, there are no fluid biomarkers or imaging tracers available for the diagnosis and treatment of other tauopathies. This study identifies specific tau species that increase in the brains of patients with CBD, PSP, FTLD-MAPT, and AD, but decrease in their cerebrospinal fluid. Measurements of these specific tau species in cerebrospinal fluid can differentiate between different diseases and aid in the diagnosis and clinical trial design of primary tauopathies.

NATURE MEDICINE (2022)

Article Clinical Neurology

CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

Joel Simren et al.

Summary: The study evaluated the performance of the tau368/t-tau ratio in capturing tangle pathology and its correlation with severity of clinical symptoms. Results showed that in individuals with symptomatic AD, the tau368/t-tau ratio was more closely related to tau PET SUVR and cognitive performance.

ALZHEIMERS RESEARCH & THERAPY (2022)

Article Clinical Neurology

A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing

Anne M. van Nifterick et al.

Summary: In this study, a computational brain network model was used to investigate the abnormalities of neuronal hyperexcitability and inhibitory interneuron dysfunction in early-stage Alzheimer's disease (AD). The findings suggest that neuronal hyperactivity can lead to oscillatory slowing, likely due to hyperexcitation of pyramidal neurons or reduced excitability of inhibitory interneurons in AD. This supports the hypothesis that neuronal hyperactivity underlies E/I imbalance and whole-brain network dysfunction in prodromal AD.

ALZHEIMERS RESEARCH & THERAPY (2022)

Review Psychiatry

Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?

Helena Targa Dias Anastacio et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disorder with no cure. Identifying early changes in the disease course could provide new therapeutic targets. Hyperactivity is a characteristic in early stages of the disease, progressing to hypoactivity later. Neuronal excitability changes, including abnormal levels of intracellular Ca2+ and glutamate, pathological proteins, and genetic risk factors, play important roles. Hyperexcitability could be a predictive marker of cognitive dysfunction.

TRANSLATIONAL PSYCHIATRY (2022)

Article Multidisciplinary Sciences

Tau isoform-specific enhancement of L-type calcium current and augmentation of afterhyperpolarization in rat hippocampal neurons

Georgiana F. Stan et al.

Summary: Accumulation of tau protein in dementia can lead to cognitive impairment. The association between tau protein and Ca-V beta 3 subunit stabilizes L-type channels in the membrane and increases calcium influx.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Thomas K. Karikari et al.

Summary: Plasma phosphorylated-tau181 (p-tau181) is a promising blood-based biomarker specific for Alzheimer's disease (AD), showing high diagnostic accuracy and increasing levels with disease progression.

MOLECULAR PSYCHIATRY (2021)

Article Clinical Neurology

CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease

Kanta Horie et al.

Summary: The study analyzed MTBR-Tau species in Alzheimer's disease and control CSF using sequential immunoprecipitation and chemical extraction methods followed by mass spectrometry. The species containing the region beginning at residue 243 were found to be highly correlated with tau PET and cognitive measures. This suggests that CSF level of tau species containing the upstream region of MTBR may serve as biomarkers to stage Alzheimer's disease and track the development of tau-directed therapeutics.

BRAIN (2021)

Article Medicine, Research & Experimental

P-tau235: a novel biomarker for staging preclinical Alzheimer's disease

Juan Lantero-Rodriguez et al.

Summary: Alzheimer's disease has a long preclinical phase and requires biomarkers for early pathological changes. P-tau235 may be a key feature and staging biomarker. A new CSF p-tau235 assay shows promise in clinical research.

EMBO MOLECULAR MEDICINE (2021)

Review Biology

Tau Oligomers Neurotoxicity

Grazyna Niewiadomska et al.

Summary: Tau oligomers (TauOs) formed during the early stages of tau aggregation play a key role in triggering neuronal loss and behavioral impairments in tauopathies like Alzheimer's disease.

LIFE-BASEL (2021)

Article Clinical Neurology

Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology

Nicholas J. Ashton et al.

Summary: Plasma phosphorylated tau231 is a promising biomarker for detecting Alzheimer's disease, accurately distinguishing AD patients from others and showing potential for early detection of pathology. Its performance is strong across various disease settings and it correlates well with other indicators of AD progression.

ACTA NEUROPATHOLOGICA (2021)

Article Clinical Neurology

Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates

Dibyadeep Datta et al.

Summary: Aged monkeys naturally develop hyperphosphorylated tau, including AD biomarkers and early tau pathology markers, which correlates with evidence of increased calcium leak. In vitro, calcium also regulates early tau phosphorylation. Blocking RyRs with S107 improves neuronal firing and cognitive performance in aged macaques, suggesting dysregulated calcium signaling can be a potential therapeutic target.

ALZHEIMERS & DEMENTIA (2021)

Article Biology

Truncating tau reveals different pathophysiological actions of oligomers in single neurons

Emily Hill et al.

Summary: Research suggests that tau protein plays a role in maintaining neuronal structure, with its oligomers potentially altering neuronal excitability by affecting voltage-gated sodium channels. Truncating the tau molecule allows for analysis of the effects of different regions on neuronal properties, highlighting a tau-mediated alteration in the voltage-gated sodium channel currents.

COMMUNICATIONS BIOLOGY (2021)

Review Neurosciences

Cellular and pathological heterogeneity of primary tauopathies

Dah-eun Chloe Chung et al.

Summary: Pathological tau can promote aggregation and propagation of endogenous tau, but tauopathies differ in terms of predominant tau isoforms and selective vulnerability of brain regions. Variability in tau pathology in neuronal and glial cells challenges our understanding of tauopathies and the development of therapeutic strategies.

MOLECULAR NEURODEGENERATION (2021)

Review Neurosciences

Contribution of Neuronal and Glial Two-Pore-Domain Potassium Channels in Health and Neurological Disorders

Yuncheng Luo et al.

Summary: This review highlights the crucial role of K2P channels in the nervous system, including their involvement in regulating membrane potential, cellular excitability, and potassium homeostasis. Additionally, it discusses the potential relevance of glial K2P channels in neurological disorders.

NEURAL PLASTICITY (2021)

Article Clinical Neurology

CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease

Kanta Horie et al.

Summary: The study analyzed MTBR-tau species in CSF and found that tau species containing the upstream region of MTBR were highly correlated with tau PET and cognitive assessments in Alzheimer's disease, suggesting they could serve as biomarkers for staging Alzheimer's disease and tracking tau-directed therapeutics development.

BRAIN (2021)

Article Psychology, Developmental

The rhythm of learning: Theta oscillations as an index of active learning in infancy

Katarina Begus et al.

DEVELOPMENTAL COGNITIVE NEUROSCIENCE (2020)

Editorial Material Clinical Neurology

Tau suppresses neuronal activity in vivo, even before tangles form

Marc Aurel Busche

BRAIN (2019)

Review Neurosciences

Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease

Eleonora Ambrad Giovannetti et al.

BRAIN RESEARCH (2019)

Article Multidisciplinary Sciences

A vicious cycle of β amyloid-dependent neuronal hyperactivation

Benedikt Zott et al.

SCIENCE (2019)

Article Mathematical & Computational Biology

Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease

Leon Stefanovski et al.

FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2019)

Article Clinical Neurology

Hypersynchronization in mild cognitive impairment: the 'X' model

Sandra Pusil et al.

BRAIN (2019)

Article Clinical Neurology

Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease

Maria Joao Leitao et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Neurosciences

Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease

Tara E. Tracy et al.

CURRENT OPINION IN NEUROBIOLOGY (2018)

Article Neurosciences

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease

Christian Sandoe Musaeus et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Biochemistry & Molecular Biology

Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model

Siddhartha Mondragon-Rodriguez et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Neurosciences

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato et al.

NEURON (2018)

Review Medicine, General & Internal

Biomarkers for Alzheimer's disease: current status and prospects for the future

K. Blennow et al.

JOURNAL OF INTERNAL MEDICINE (2018)

Article Clinical Neurology

A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor

Pengcheng Han et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)

Article Multidisciplinary Sciences

Human hippocampal theta power indicates movement onset and distance travelled

Daniel Bush et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Mathematics, Applied

Julia: A Fresh Approach to Numerical Computing

Jeff Bezanson et al.

SIAM REVIEW (2017)

Article Geriatrics & Gerontology

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage

Scott S. Shafiei et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Review Clinical Neurology

Alzheimer's disease: The state of the art in resting-state magnetoencephalography

M. M. A. Engels et al.

CLINICAL NEUROPHYSIOLOGY (2017)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

LANCET (2016)

Review Neurosciences

Network abnormalities and interneuron dysfunction in Alzheimer disease

Jorge J. Palop et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

M. Fa et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

Neuronal hyperactivity - A key defect in Alzheimer's disease?

Marc Aurel Busche et al.

BIOESSAYS (2015)

Article Neurosciences

Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD

Philip Regan et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Biochemical Research Methods

Experimentally Verified Parameter Sets for Modelling Heterogeneous Neocortical Pyramidal-Cell Populations

Paul M. Harrison et al.

PLOS COMPUTATIONAL BIOLOGY (2015)

Article Neurosciences

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice

Andreas Bjorefeldt et al.

JOURNAL OF PHYSIOLOGY-LONDON (2015)

Review Neurosciences

The Theta-Gamma Neural Code

John E. Lisman et al.

NEURON (2013)

Article Multidisciplinary Sciences

Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease

Jere E. Meredith et al.

PLOS ONE (2013)

Article Biochemistry & Molecular Biology

Tau oligomers and tau toxicity in neurodegenerative disease

Sarah M. Ward et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2012)

Article Biochemistry & Molecular Biology

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

Cristian A. Lasagna-Reeves et al.

FASEB JOURNAL (2012)

Review Clinical Neurology

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Multidisciplinary Sciences

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

Cristian A. Lasagna-Reeves et al.

SCIENTIFIC REPORTS (2012)

Article Biochemical Research Methods

Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's Disease

Willem de Haan et al.

PLOS COMPUTATIONAL BIOLOGY (2012)

Article Clinical Neurology

Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy

Johanna L. Crimins et al.

ACTA NEUROPATHOLOGICA (2011)

Article Medicine, Research & Experimental

Neuropathological Alterations in Alzheimer Disease

Alberto Serrano-Pozo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

Article Biochemistry & Molecular Biology

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy

Catherine M. Cowan et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2010)

Review Neurosciences

Functional Alterations in Memory Networks in Early Alzheimer's Disease

Reisa A. Sperling et al.

NEUROMOLECULAR MEDICINE (2010)

Article Chemistry, Multidisciplinary

Nonlinear dynamical analysis of carbachol induced hippocampal oscillations in mice

Metin Akay et al.

ACTA PHARMACOLOGICA SINICA (2009)

Article Multidisciplinary Sciences

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

Vikaas S. Sohal et al.

NATURE (2009)

Article Multidisciplinary Sciences

Driving fast-spiking cells induces gamma rhythm and controls sensory responses

Jessica A. Cardin et al.

NATURE (2009)

Article Neurosciences

Self-generated theta oscillations in the hippocampus

Romain Goutagny et al.

NATURE NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Distinct patterns of brain activity in young carriers of the APOE-ε4 allele

Nicola Filippini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Computer Science, Cybernetics

Extracting non-linear integrate-and-fire models from experimental data using dynamic I-V curves

Laurent Badel et al.

BIOLOGICAL CYBERNETICS (2008)

Article Psychology, Biological

Quantitative EEG in early Alzheimer's disease patients - Power spectrum and complexity features

Balazs Czigler et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2008)

Article Clinical Neurology

Resting-state oscillatory brain dynamics in Alzheimer disease

Willem de Haan et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2008)

Article Neurosciences

Dynamic I-V curves are reliable predictors of naturalistic pyramidal-neuron voltage traces

Laurent Badel et al.

JOURNAL OF NEUROPHYSIOLOGY (2008)

Article Multidisciplinary Sciences

Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease

Marc Aurel Busche et al.

SCIENCE (2008)

Article Geriatrics & Gerontology

Increased fMRI responses during encoding in mild cognitive impairment

Anne Hämäläinen et al.

NEUROBIOLOGY OF AGING (2007)

Article Clinical Neurology

Familial risk for Alzheimer's disease alters fMRI activation patterns

SS Bassett et al.

BRAIN (2006)

Article Neurosciences

Human hippocampal theta activity during virtual navigation

AD Ekstrom et al.

HIPPOCAMPUS (2005)

Article Clinical Neurology

Individual analysis of EEG frequency and band power in mild Alzheimer's disease

DV Moretti et al.

CLINICAL NEUROPHYSIOLOGY (2004)

Review Clinical Neurology

EEG dynamics in patients with Alzheimer's disease

JS Jeong

CLINICAL NEUROPHYSIOLOGY (2004)

Article Biochemistry & Molecular Biology

Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

C Andorfer et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Neurosciences

Facilitation at single synapses probed with optical quantal analysis

TG Oertner et al.

NATURE NEUROSCIENCE (2002)

Article Clinical Neurology

Diagnostic value of quantitative EEG in Alzheimer's disease

K Bennys et al.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2001)

Review Neurosciences

Quantal currents at single-site central synapses

C Auger et al.

JOURNAL OF PHYSIOLOGY-LONDON (2000)